# A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer

> **NCT04161781** · — · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 10 (actual)

## Conditions studied

- Esophagogastric Cancer
- Esophagus Cancer
- Esophageal Cancer
- Gastric Cancer
- Gastric Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
- Gastroesophageal Junction Squamous Cell Carcinoma

## Interventions

- **DRUG:** 18F-BMS-986229 Injection
- **DRUG:** IV 18F-BMS-986229
- **DIAGNOSTIC_TEST:** PET/CT Scan

## Key facts

- **NCT ID:** NCT04161781
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-12
- **Primary completion:** 2024-03-06
- **Final completion:** 2024-03-06
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04161781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04161781, "A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT04161781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*